Publications by authors named "Shakti D Shukla"

Claim this Profile
F
Faecal microbial transfer and complex carbohydrates mediate protection against COPD.
Kurtis F Budden, Shakti D Shukla, Kate L Bowerman, Annalicia Vaughan, Shaan L Gellatly

Gut· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Pathogen targeting in chronic respiratory diseases: prevention, therapy and management.
Shakti D Shukla, Kamal Dua, Ronan F O'Toole

Front Pharmacol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nutraceuticals and COVID-19: A mechanistic approach toward attenuating the disease complications.
Keshav Raj Paudel, Vyoma Patel, Sukriti Vishwas, Saurabh Gupta, Sumit Sharma, Shakti Dhar Shukla

J Food Biochem· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancements in nanotherapeutics targeting senescence in chronic obstructive pulmonary disease.
Keshav Raj Paudel, Meenu Mehta, Shakti Dhar Shukla, Nisha Panth, Dinesh Kumar Chellappan

Nanomedicine (Lond)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the role of antibiotics and steroids in managing respiratory diseases.
Dinesh K Chellappan, Parteek Prasher, Shakti D Shukla, Tong W Yee, Tiong K Kah

J Biochem Mol Toxicol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of chronic airway diseases using nutraceuticals: Mechanistic insight.
Venkata Sita Rama Raju Allam, Dinesh Kumar Chellappan, Niraj Kumar Jha, Madhur D Shastri, Gaurav Gupta, Shakti D Shukla

Crit Rev Food Sci Nutr· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Targeting intercellular adhesion molecule-1 (ICAM-1) to reduce rhinovirus-induced acute exacerbations in chronic respiratory diseases.
Shakti D Shukla, Madhur D Shastri, Swaroop K Vanka, Niraj Kumar Jha, Harish Dureja

Inflammopharmacology· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting intercellular adhesion molecule-1 (ICAM-1) to reduce rhinovirus-induced acute exacerbations in chronic respiratory diseases.
Shakti D Shukla, Madhur D Shastri, Swaroop K Vanka, Niraj Kumar Jha, Harish Dureja

Inflammopharmacology· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Air Pollution as a Risk Factor for Lung Cancer: Potential Mechanisms.
Chris Ward, Shakti D Shukla, E Haydn Walters

Am J Respir Crit Care Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases.
Daljeet Singh Dhanjal, Parvarish Sharma, Meenu Mehta, Murtaza M Tambuwala, Parteek Prasher, Shakti D Shukla

Future Med Chem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptors, innate immune system, and lung diseases: a vital trilateral association.
Vyoma K Patel, Keshav R Paudel, Shakti D Shukla, Gang Liu, Brian G Oliver

EXCLI J· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Niraj Kumar Jha, Shreesh Ojha, Saurabh Kumar Jha, Harish Dureja, Sachin Kumar Singh, Shakti D Shukla

J Mol Neurosci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting LIN28: a new hope in prostate cancer theranostics.
Garima Shrivastava, Alaa Aa Aljabali, Seyed Hossein Shahcheraghi, Marzieh Lotfi, Madhur D Shastri, Shakti D Shukla

Future Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseases.
Madhur D Shastri, Venkata Sita Rama Raju Allam, Shakti D Shukla, Niraj Kumar Jha, Keshav Raj Paudel

Life Sci· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silicosis: Pathogenesis and utility of animal models of disease.
Eugene Haydn Walters, Shakti D Shukla

Allergy· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases.
Meenu Mehta, Keshav Raj Paudel, Shakti Dhar Shukla, Venkata Sita Rama Raju Allam, Vinod Kumar Kannaujiya

J Control Release· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Underappreciated Role of Epithelial Mesenchymal Transition in Chronic Obstructive Pulmonary Disease and Its Strong Link to Lung Cancer.
Malik Quasir Mahmood, Shakti D Shukla, Chris Ward, Eugene Haydn Walters

Biomolecules· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Female gender as a risk factor for developing COPD.
Shakti D Shukla, Madhur D Shastri, Niraj Kumar Jha, Gaurav Gupta, Dinesh Kumar Chellappan

EXCLI J· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro.
Keshav Raj Paudel, Ridhima Wadhwa, Xin Nee Tew, Natalie Jia Xin Lau, Thiagarajan Madheswaran, Shakti D Shukla

Life Sci· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Appraisal of the Current Scenario in Vaccine Research for COVID-19.
Wai Chin Chong, Dinesh K Chellappan, Shakti D Shukla, Gregory M Peterson, Rahul P Patel

Viruses· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fully integrating pathophysiological insights in COPD: an updated working disease model to broaden therapeutic vision.
E Haydn Walters, Shakti D Shukla, Malik Q Mahmood, Chris Ward

Eur Respir Rev· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: a PCR validation.
Meenu Mehta, Keshav Raj Paudel, Shakti D Shukla, Madhur D Shastri, Saurabh Satija

Future Med Chem· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An overview of vaccine development for COVID-19.
Seyed H Shahcheraghi, Jamshid Ayatollahi, Alaa Aa Aljabali, Madhur D Shastri, Shakti D Shukla

Ther Deliv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The complex interplay between endoplasmic reticulum stress and the NLRP3 inflammasome: a potential therapeutic target for inflammatory disorders.
Wai Chin Chong, Madhur D Shastri, Gregory M Peterson, Rahul P Patel, Prabuddha S Pathinayake, Shakti Dhar Shukla

Clin Transl Immunology· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 in underlying COPD Patients.
Krishna Sunkara, Venkata Raj Allam, Shakti D Shukla, Dinesh K Chellappan, Gaurav Gupta

EXCLI J· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis